Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Bladder cancer
Stage/Subtype:  stage II bladder cancer
Country:  U.S.A.
Trial Type:  Treatment
Results 1-12 of 12 for your search:
Start Over
Transurethral Resection of Bladder Tumors Using PK Button Vaporization Electrode or Monopolar Loop Electrocautery in Treating Patients with Bladder Cancer
Phase: Phase IV
Type: Treatment
Age: 18 to 89
Trial IDs: WCI2119-11, NCI-2013-00065, IRB00053735, NCT01567462
Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: S1011, NCI-2011-02604, CDR0000686574, SWOG-S1011, NCT01224665
Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients with Bladder Cancer
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 8027, NCI-2013-01614, NCT01938573
Gemcitabine Hydrochloride and Cisplatin in Treating Patients With High-Grade Urothelial Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 10-208, NCI-2010-02376, NCT01261728
Biological Therapy in Improving Immune Reconstitution after Chemotherapy in Older Patients with Stage I-III Breast, Stage II Bladder, or Stage II-III Colorectal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 60 and over
Trial IDs: 11-C-0146, NCI-2013-01487, 110146, P09590, NCT01339000
Dose Dense Gemcitabine Hydrochloride and Cisplatin in Treating Patients with Muscle-Invasive Bladder Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 12-071, NCI-2012-00649, NCT01589094
Gemcitabine Hydrochloride, Carboplatin, and Panitumumab before Surgery in Treating Patients with Bladder Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 10-103, NCI-2013-01611, NCT01916109
Erlotinib Hydrochloride in Treating Patients with Bladder Cancer Undergoing Surgery
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CO12336, NCI-2014-01320, HHSN261201200033I, N01-CN-2012-00033, UWI2013-01-02, NCT02169284
Gene Expression Profiling in Predicting Chemotherapy Response in Patients with Localized, Muscle-Invasive Bladder Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: S1314, NCI-2014-00850, NCT02177695
Image-Guided Radiation Therapy and Gemcitabine Hydrochloride in Treating Patients with Stage II-III Bladder Cancer
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 10-031, NCI-2010-01234, NCT01104350
MRI Before and During Surgery in Diagnosing Patients With Bladder Cancer
Phase: No phase specified
Type: Diagnostic, Treatment
Age: 18 and over
Trial IDs: OSU-08063, NCI-2012-00937, 2009C0001, NCT00938145
BCG Solution in Treating Patients with Invasive Bladder Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: HSC2014-0002H, NCI-2013-02367, CTRC 13-0051, NCT02365207
Start Over